Document Detail


Outcomes of second-trimester pregnancy terminations with misoprostol: comparing 2 regimens.
MedLine Citation:
PMID:  16098889     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this study was compare outcomes of second-trimester pregnancy terminations with misoprostol between our previous low- (200 microg every 12 h) and present high-dose (400 microg every 6 h) regimens. STUDY DESIGN: This was an historic cohort study that was conducted from June 1996 to February 2004 on women undergoing medical termination of pregnancy at 13 to 27 weeks. Exclusion criteria were multiple gestation, placenta previa, and primary use of another medication. RESULTS: The cohort consisted of 147 women. For the low- (n = 100) and high-dose (n = 47) groups, respectively, median times to delivery were 22.5 vs 13.25 hours (P = .001). More patients in the high-dose group were delivered vaginally within 24 (81% vs 54%; P = .002) and 48 hours (98% vs 84%; P = .014). Fewer patients in the high-dose group required a second abortifacient (6% vs 27%; P = .004). Clinical chorioamnionitis was more common in the high-dose group (P = .03). One patient experienced a uterine rupture and is included in the analysis. Side effects were uncommon and did not differ between groups. CONCLUSION: Our present high-dose regimen for misoprostol terminations of pregnancy effects delivery more rapidly without an appreciable increase in side effects or complications.
Authors:
Rodney K Edwards; Shireen M Sims
Related Documents :
12127639 - Second trimester abortion by laminaria followed by vaginal misoprostol or intrauterine ...
17896259 - Pregnancy termination using vaginal misoprostol in women with more than one caesarean s...
2976579 - Selective termination of multiple gestations.
14624219 - Misoprostol and pregnancy: ever-increasing indications of effective usage.
3919839 - Sequelae and support after termination of pregnancy for fetal malformation.
16041629 - Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isoso...
7612099 - Umbilical venous doppler waveform without fetal breathing: its significance.
15352859 - Abnormal vomer development in human fetuses with isolated cleft palate.
12693619 - Fetuses subsequently born premature are smaller than gestational age-matched fetuses no...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  193     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-15     Completed Date:  2005-09-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  544-8; author reply 548-50     Citation Subset:  AIM; IM    
Affiliation:
Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, FL, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage*,  adverse effects
Abortion, Induced* / methods
Adult
Chorioamnionitis / chemically induced
Female
Humans
Misoprostol / administration & dosage*,  adverse effects
Pregnancy
Pregnancy Trimester, Second
Treatment Outcome
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of non-nutritive sucking to decrease the physiologic pain response during neonatal circumcis...
Next Document:  Assessment of the understanding of the risks and benefits of hormone replacement therapy (HRT) in pr...